✦ LIBER ✦

Short-term use of steroids in transplant recipients with recurrent HCV infection is associated with early steatosis and slow progression of hepatic fibrosis

✍ Scribed by Angelico, Mario; Palmieri, Gianpiero; Battista, Serena; Casarelli, Flavio; Di Paolo, Daniele; Piccolo, Paola; Petrolati, Alessandra; Cicerone, Claudia; Lionetti, Raffaella; Tisone, Giuseppe

Book ID: 123306404
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 490 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)83695-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early steatosis in transplant recipients

Early steatosis in transplant recipients with recurrent HCV infection is associated with early short term use of steroids and delayed progression of hepatic fibrosis

✍ M. Angelico; G. Palmieri; S. Battista; F. Casarelli; D. Di Paolo; A. Petrolati; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 142 KB

1 Early steatosis in transplant recipien

1 Early steatosis in transplant recipients with recurrent HCV infection: Relations with use of steroids and hepatic fibrosis progression

✍ R. Lionetti; G. Palmieri; S. Battista; F. Casarelli; D. Di Paolo; A. Petrolati; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Early steatosis and past HBV infection p

Early steatosis and past HBV infection predict fibrosis progression in liver transplant recipients with recurrent HCV infection

✍ Angelico, Mario; Palmieri, Giampiero; Di Paolo, Daniele; Torri, Elena; Iaria, Gi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 177 KB

122Early steatosis and past HBV infectio

122Early steatosis and past HBV infection predict fibrosis progression in liver transplant recipients with recurrent HCV infection

✍ TISONE, G; ANGELICO, M; PALMIERI, G; DIPAOLO, D; TORRI, E; IARIA, G; BAIOCCHI, L 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Hepatic steatosis at 1 year is an additi

Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus

✍ Danielle Brandman; Andrea Pingitore; Jennifer C. Lai; John P. Roberts; Linda Fer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

Recurrent hepatitis C virus (HCV) is the most common cause of graft loss for HCV-infected recipients of liver transplantation (LT). Diabetes mellitus (DM) has been associated with increased rates of fibrosis progression, but whether steatosis affects post-LT outcomes independently of DM is unclear.

1028 Treatment of acute cellular rejecti

1028 Treatment of acute cellular rejection with high-dose steroids, but not modulation of baseline immunosuppression, is associated with severe HCV recurrence in both living and deceased donor liver transplant recipients

✍ GAGLIO, P; PARK, J; LEFKOWITCH, J; EMOND, J; BROWNJR, R 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB